Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Low oxygen levels affect the behavior of certain proteins in human skin cells.

Activin A and follistatin control when ear hair cells form in mice.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Overexpression of ALK2 in hair follicles disrupts skin development and slows wound healing.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

Clascoterone may be an effective topical treatment for hair loss.

KY19382 speeds up wound healing by activating a specific cell signaling pathway.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

ACTH promotes hair growth in mink, but α-MSH does not.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

2-Methoxyestradiol causes cancer cell death by activating specific pathways, but androgens can block this effect.